| Patent application number | Description | Published |
|---|
| 20090202905 | CATHODE ACTIVE MATERIAL, CATHODE THEREWITH AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY - The invention provides a cathode active material that includes: a particle containing a cathode material capable of absorbing and releasing an electrode reactive material; and a film that is disposed at least partially to the particle and contains a metal salt represented by a formula (1). | 08-13-2009 |
| 20100028768 | POSITIVE ELECTRODE ACTIVE MATERIAL, POSITIVE ELECTRODE USING THE SAME AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY - A positive electrode active material includes: a complex oxide particle containing at least lithium and one or plural transition metals; and a coating layer provided in at least a part of the complex oxide particle, wherein the coating layer contains at least one element M which is different from the principal transition metal constituting the complex oxide particle and which is selected among elements belonging to the Groups 2 to 13, and at least one element X selected among phosphorus (P), silicon (Si) and germanium (Ge), and the element M and the element X show different distribution from each other in the coating layer. | 02-04-2010 |
| 20100173197 | CATHODE ACTIVE MATERIAL, METHOD OF MANUFACTURING THE SAME AND BATTERY - A cathode active material capable of obtaining a high capacity and capable of improving stability or low-temperature characteristics, a method of manufacturing the same, and a battery are provided. A cathode ( | 07-08-2010 |
| 20110020708 | POSITIVE ELECTRODE ACTIVE MATERIAL, POSITIVE ELECTRODE, AND NONAQUEOUS ELECTROLYTE CELL - Disclosed herein is a positive electrode active material wherein at least one metallic element M | 01-27-2011 |
| 20110059367 | POSITIVE ELECTRODE ACTIVE MATERIAL, POSITIVE ELECTRODE, NONAQUEOUS ELECTROLYTE CELL, AND METHOD OF PREPARING POSITIVE ELECTRODE ACTIVE MATERIAL - Disclosed herein is a positive electrode active material prepared by mixing a lithium-containing compound, a compound containing a transition metal to be put into a solid solution, and a compound containing a metallic element M2 different from the transition metal, and firing the mixture to form composite oxide particles, depositing a compound containing at least one element selected from among sulfur (S), phosphorus (P) and fluorine (F) on surfaces of the particles, and firing the particles, whereby each of the particles is provided with a concentration gradient such that the concentration of the metallic element M2 increases from the center toward the surface of the particle, and at least one element selected from among (S), (P) and (F) is made present in the form of being aggregated at the surfaces of the composite oxide particles. | 03-10-2011 |
| Patent application number | Description | Published |
|---|
| 20090214753 | High Rebaudioside-A Plant - A novel plant belonging to the | 08-27-2009 |
| 20100249315 | Bio-based coating composition and its coated article - There are provided: a bio-based coating composition which is a bio-based ingredient coating composition in consideration of environment and does not need any expensive ingredient and is also excellent in hydrolysis resistance; and an article coated with the coating composition. The bio-based coating composition is characterized by comprising the following film-forming ingredients: a lactic acid polymer (A) which contains a polyfunctional compound having a hydroxyl group and/or a carboxyl group in a functionality of not less than 3 and lactic acid as essential monomer ingredients and has a specific SP value; and a resin (B) which contains a hydroxyl group and/or a carboxyl group and has a specific SP value; wherein the difference (ΔSP) between the SP values of the lactic acid polymer (A) and the resin (B) is in the range of 0.2 to 4.0. The coated article is characterized by being obtained by being coated with the aforementioned coating composition. | 09-30-2010 |
| 20110009518 | Photosetting type bio-based coating composition and its coated article - There are provided a photosetting type bio-based coating composition and its coated article, wherein the coating composition has a sufficient hydrolysis resistance and a sufficient crosslinking density so as to be excellent in such as long-term stability, and is inexpensive, and is applicable also to an aqueous solvent. The photosetting type bio-based coating composition according to the present invention is characterized by comprising: a bio-based photopolymerizable compound as a film-forming ingredient which compound has at least one lactic acid unit and at least one photopolymerizable group together in a molecule; and a photopolymerization initiator. The coated article according to the present invention is characterized by being obtained by being coated with the aforementioned coating composition. | 01-13-2011 |
| 20110023192 | NOVEL STEVIA VARIETY AND METHOD OF PRODUCING SWEETENER - High-purity stevioside sweeteners are being provided. Stevia Rebaudiana Bertoni varieties were identified using DNA analysis after cross and selective breeding were implemented. By crossing these varieties, a novel variety which enables continuous cultivation of the specific variety was developed (Deposition No. FERM BP-10870). Extracting the dried leaves of this variety assures consistent high-concentration of stevioside, which makes it possible to produce various favorable stevioside sweeteners. | 01-27-2011 |
| Patent application number | Description | Published |
|---|
| 20090149404 | Oligonucleotide analogues and methods utilizing the same - A method for the prevention or treatment in a mammal of a disease preventable or treatable by the pharmacologically useful antisense or antigene activity of an oligonucleotide analogue or a pharmacologically acceptable salt thereof in the body of said mammal, which method comprises administering to said mammal in need of such prevention or treatment a pharmaceutically effective amount of an oligonucleotide analogue comprising two or more nucleoside units, wherein at least one of said nucleoside units is a structure of the formula (2): | 06-11-2009 |
| 20100035976 | Method of treating a tumor or a viral disease by administering a 2' , 5' -oligoadenylate analog - A method of treating a tumor or a viral disease by administering to a human the following 2′,5′-oligoadenylate analog: | 02-11-2010 |
| 20100209490 | IMMUNOLIPOSOME INDUCING APOPTOSIS INTO CELL EXPRESSING DEATH DOMAIN-CONTAINING RECEPTOR - The present invention relates to an immunoliposome preparation having a therapeutic effect on cancer, autoimmune disease, or inflammatory disease. Specifically, the present invention relates to an immunoliposome comprising, as a constituent, an antibody capable of inducing the apoptosis of cells expressing a death domain-containing receptor. | 08-19-2010 |
| 20110009471 | Oligonucleotide analogues and methods utilizing the same - A method for the prevention or treatment in a mammal of a disease preventable or treatable by the pharmacologically useful antisense or antigene activity of an oligonucleotide analogue or a pharmacologically acceptable salt thereof in the body of said mammal, which method comprises administering to said mammal in need of such prevention or treatment a pharmaceutically effective amount of an oligonucleotide analogue comprising two or more nucleoside units, wherein at least one of said nucleoside units is a structure of the formula (2): | 01-13-2011 |
| Patent application number | Description | Published |
|---|
| 20090292441 | Control Apparatus for Internal Combustion Engine - A control apparatus ( | 11-26-2009 |
| 20100037860 | INTERNAL COMBUSTION ENGINE CONTROLLING APPARATUS - In a predetermined low-temperature startup state (in a rich atmosphere), in principle, over-advanced ignition control for advancing ignition timing beyond MBT and intake-synchronized injection control for causing the entire amount of to-be-injected fuel to undergo intake-synchronized injection are executed. Thus, the peak of intra-cylinder temperature increases, and the amount of port-adhering fuel decreases, whereby the emission amount of unburnt HC can be reduced. However, when the PM emission amount exceeds a PM permissible amount, instead of the intake-synchronized injection control, there is performed processing for causing a portion of the to-be-injected fuel to undergo intake-unsynchronized injection and causing the remaining fuel to undergo intake-synchronized injection. Thus, the amount of intra-cylinder-adhering fuel decreases, and the partial oxidation reaction of the intra-cylinder-adhering fuel, which is a cause of generation of PM, is suppressed. As a result, the PM emission amount decreases, whereby the PM emission amount can be suppressed to the PM permissible amount. | 02-18-2010 |
